搜索临床试验以:Modified release (Oral Controlled Absorption System (OCAS))
总计255493个结果
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.完全的
-
Astellas Pharma Europe B.V.完全的
-
Astellas Pharma Inc完全的
-
Astellas Pharma Europe B.V.完全的下尿路症状 | 良性前列腺增生症比利时, 意大利, 法国, 奥地利, 英国, 荷兰, 波兰, 斯洛伐克, 白俄罗斯, 德国, 捷克语
-
Masonic Cancer Center, University of MinnesotaNational Center for Complementary and Integrative Health (NCCIH)完全的
-
Astellas Pharma IncBoehringer Ingelheim; Astellas Pharma Europe Ltd.完全的良性前列腺增生症
-
Astellas Pharma Inc完全的
-
Beth Israel Deaconess Medical CenterHong Kong Association for Health Care; Integrated Chinese Medicine Holdings完全的
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Montpellier; University Hospital, Bordeaux; Saint Antoine University Hospital 和其他合作者完全的
-
Astellas Pharma IncAstellas Pharma Europe B.V.完全的膀胱过度活动症 | 米拉贝隆的药代动力学 | 神经源性逼尿肌过度活跃比利时, 丹麦, 挪威, 波兰, 塞尔维亚
-
Astellas Pharma Europe B.V.完全的下尿路症状 | 良性前列腺增生症比利时, 意大利, 法国, 奥地利, 英国, 荷兰, 匈牙利, 俄罗斯联邦, 波兰, 斯洛伐克, 捷克共和国, 白俄罗斯, 德国
-
Fudan UniversityQilu Hospital of Shandong University; First Affiliated Hospital Xi'an Jiaotong University; Southern... 和其他合作者招聘中
-
Astellas Pharma Europe B.V.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
National Institute of Allergy and Infectious Diseases...完全的
-
Overseas Pharmaceuticals, Ltd.Virginia Contract Research Organization Co., Ltd.终止
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Icahn School of Medicine at Mount SinaiU.S. Department of Education完全的